Tags : Capacity

COVID-19 Pharma

Johnson & Johnson Signs a Manufacturing Agreement with the Catalent

Shots: The alliance includes joint investment and tech transfer to accelerate rapid scale-up of segregated manufacturing capacity over the coming months for supporting J&J’s vaccine candidates Catalent will accelerate the availability of manufacturing capacity and prepare for large-scale commercial manufacturing at its facility in Bloomington and plans to hire ~300 additional employees for the program […]Read More